Browse Data and Analysis

Sri Lanka’s agricultural biotechnology policies remain unchanged. Over the past year, there has been no progress in the approval of its draft Biosafety Act, which establishes a system to protect biodiversity, the environment and human, plant and animal health while minimizing the risks of biotechnology.

In January 2024, Nigeria became the second country in Africa to approve the commercial release of four biotech (TELA) maize varieties.